Zydus Pharmaceuticals (USA) Inc gets final USFDA approval to market Roflumilast…
Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug exclusivity, Cadlia Healthcare said in a regulatory filing.…